technetium has been researched along with 2-piperidone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anant, S; Awasthi, V; Lagisetty, P; Sahoo, K; Subramaniam, D | 1 |
| Abdelbary, AA; Aboumanei, MH; El-Kolaly, MT; Ibrahim, IT; Tadros, MI | 1 |
2 other study(ies) available for technetium and 2-piperidone
| Article | Year |
|---|---|
Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH).
Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; Cell Line, Tumor; Cell Proliferation; Humans; Hydrazines; Isotope Labeling; Mice; Mice, Nude; Piperidones; Radiopharmaceuticals; Rats; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2012 |
Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking, Technetium 99m Radiolabeling, and In Vivo Biodistribution Studies.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Drug Screening Assays, Antitumor; Emulsions; Female; Humans; Injections, Intralesional; Injections, Intravenous; Mice; Molecular Docking Simulation; Particle Size; Piperidones; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |